G. Suda - Gastroenterol & Hepatol, Hokkaido Univ

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 15 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

173P Lenvatinib (L) Versus Sorafenib (S) Second-Line Therapy in Hepatocellular Carcinoma (HCC) Patients Progressed to Atezolizumab Plus Bevacizumab (AB)

M. Persano,M. Rimini,S. Foti, S. Camera, F. Rossari,E. Amadeo,F. Vitiello, T. Tada,G. Suda,S. Shimose, M. Kudo,C. Yoo,J. Cheon,F. Finkelmeier,H. Y. Lim,J. Presa, L. Mascia,S. Cascinu,M. Scartozzi,A. Casadei Gardini

ANNALS OF ONCOLOGY (2024): S83-S83

引用0浏览0引用

Impact of Metformin, Statin, Aspirin and Insulin on the Prognosis of Uhcc Patients Receiving First Line Lenvatinib or Atezolizumab Plus Bevacizumab

Scientific Reportsno. 1 (2024)

引用0浏览0WOSNATURE引用

185P the Combined Role of Patients (pts) Gender and Disease Etiology on Unresectable HCC (uhcc) First-Line (1L) Treatment Outcome

S. Cesario,V. Genovesi,M. Rimini, T. Tada,G. Suda,S. Shimose, M. Kudo,F. Finkelmeier, C. Yoo,J. Presa, M.A. Iavarone, F. Marra, F.G. Foschi, E. Tamburini, S. Lonardi, F. Piscaglia,F. Salani,C. Vivaldi,A. Casadei Gardini, G. Masi

Annals of Oncology (2024)

引用0浏览0引用

BMI impact on the prognosis of unresectable HCC patients receiving first-line lenvatinib or atezolizumab plus bevacizumab

E. Amadeo,M. Persano, T. Tada,G. Suda,S. Shimose, M. Kudo,C. Yoo,F. Rossari,F. Vitiello,A. Casadei Gardini,M. Rimini

ANNALS OF ONCOLOGY (2023): S1539-S1540

引用0浏览0引用

972P Sequential Therapies after Atezolizumab Plus Bevacizumab or Lenvatinib First-Line Treatments in Advanced Hepatocellular Carcinoma

M. Persano,M. Rimini, T. Tada,G. Suda, S. Shimose, M. Kudo,J. Cheon,F. Finkelmeier,J. Presa,G. Masi,C. Yoo,S. Lonardi,F. Piscaglia,M. A. Iavarone,E. Tamburini,G. Cabibbo, M. Silletta, S. Cascinu,M. Scartozzi, A. Casadei Gardini

Annals of Oncology（2023）

引用4浏览0引用

67P Real-world data for atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma

M. Persano,M. Rimini, T. Tada,G. Suda,S. Shimose,M. Kudo,J. Cheon,F. Finkelmeier,L. Rimassa,J. Presa,G. Masi,C. Yoo,S. Lonardi,F. Piscaglia,V. Burgio,M. Scartozzi,S. Cascinu,A. Casadei Gardini

Immuno-Oncology and Technology (2022): 100172-100172

引用0浏览0引用

Atezolizumab Plus Bevacizumab Versus Lenvatinib for Unresectable Hepatocellular Carcinoma: a Large Real-Life Worldwide Population

M. Rimini,A. Casadei-Gardini, T. Tada,G. Suda,S. Shimose, M. Kudo,J. Cheon,F. Finkelmeier,H. Y. Lim, L. Rimassa, J. Presa,G. Masi,C. Yoo, S. Lonardi, F. Tovoli, S. Cascinu, A. Cucchetti

Journal of Clinical Oncology（2023）

引用27浏览0WOS引用

Nonalcoholic Steatohepatitis in Hepatocarcinoma: New Insights about Its Prognostic Role in Patients Treated with Lenvatinib

M. Rimini,M. Kudo,T. Tada,S. Shigeo, W. Kang,G. Suda,A. Jefremow,V Burgio,M. Iavarone,R. Tortora,F. Marra,S. Lonardi,E. Tamburini,F. Piscaglia,G. Masi,G. Cabibbo,F. G. Foschi,M. Silletta,T. Kumada,H. Iwamoto, T. Aoki, M. J. Goh,N. Sakamoto,J. Siebler,A. Hiraoka,T. Niizeki,K. Ueshima,T. Sho,M. Atsukawa,M. Hirooka,K. Tsuji,T. Ishikawa,K. Takaguchi,K. Kariyama,E. Itobayashi, K. Tajiri,N. Shimada, H. Shibata,H. Ochi,S. Yasuda,H. Toyoda,S. Fukunishi,H. Ohama,K. Kawata,J. Tani,S. Nakamura,K. Nouso,A. Tsutsui, T. Nagano, T. Takaaki,N. Itokawa, T. Okubo,T. Arai,M. Imai,K. Joko,Y. Koizumi,Y. Hiasa,A. Cucchetti,F. Ratti,L. Aldrighetti,S. Cascinu,A. Casadei-Gardini

ESMO open（2021）

引用21浏览0WOS引用

P-171 Lenvatinib in patients with unresectable hepatocellular carcinoma who do not meet REFLECT trial inclusion criteria

T. Sho,G. Suda,K. Ogawa, T. Kitagataya,R. Yamada, T. Shigesawa,K. Suzuki,A. Nakamura,M. Nakai,M. Natsuizaka,K. Morikawa,N. Sakamoto

ANNALS OF ONCOLOGY（2020）

引用0浏览0引用

Risk Assessment of Hepatocellular Carcinoma in Chronic Liver Disease Patients with a Combination of Liver Stiffness Measurement and Controlled Attenuation Parameter by FibroScan

K. Morikawa,T. Izumi,T. Sho,K. Suzuki,A. Nakamura, M. Ohara,N. Kawagishi,M. Umemura, M. Nakai,G. Suda,K. Ogawa, Y. Kudo, M. Nishida, M. Baba, K. Furuya,N. Sakamoto

Journal of hepatology（2018）

引用3浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn